MARKET CLOSE: NZ shares rise as vaccine news spurs optimism

MARKET CLOSE: NZ shares rise as vaccine news spurs optimism
Dan Brunskill
New Zealand shares rose as promising results from a covid-19 vaccine trial spurred optimistic investors to take positions in riskier stocks. Kathmandu Holdings led the market higher. The S&P/NZX 50 Index advanced 152.25 points, or 1.3 percent, to 11,502.52. Within the index, 33 stocks rose, 12 fell, and five unchanged. Turnover was $156 million. Markets across Asia followed Wall Street higher as investors became optimistic after positive news about a potential vaccine for covid-19 emerged overnight. Stephen Innes, chief global market s...

More Markets

NZ sharemarket up as Sanford rides the wave
Markets Market Close

NZ sharemarket up as Sanford rides the wave

Sanford’s result was its best in a decade.

Why Xero is loyal to the ASX
Markets

Why Xero is loyal to the ASX

Cloud accounting firm 'happy to show up differently', CEO says.

NZX listing costs to fall
Markets

NZX listing costs to fall

The cost of providing PFI ranges from around $150,000 to $500,000, says NZX. 

Briscoe Group has plans for smaller ‘Metro stores’
Retail

Briscoe Group has plans for smaller ‘Metro stores’

There could be an opportunity for up to 15 new stores, COO Andrew Scott says.